Glioblastoma-specific anticancer activity of pheophorbide a from the edible red seaweed Grateloupia elliptica

46Citations
Citations of this article
66Readers
Mendeley users who have this article in their library.

Abstract

The chlorophyll-related compound pheophorbide a (Pa) was successively purified from an edible red seaweed, Grateloupia elliptica, using silica, octadecyl silica column chromatography and reversed phase-high-performance liquid chromatography, as well as the cell cycle inhibitory and apoptotic effects of Pa being investigated in U87MG glioblastoma cells. The Pa exhibited strong anticancer effects in the absence of direct photo-irradiation against various cancer cell lines, including U87MG, SK-OV-3, and HeLa cells. Among the cancer cells, the strongest anticancer activity of Pa exhibited on U87MG cells with IC50 values of 2.8 μg/ml. In addition, Pa specifically had cytostatic activity on glioblastoma cells rather than human umbilical vein endothelial cells. Analysis of the cell cycle distribution showed that Pa induced G0/G1 arrest of U87 MG cells. In addition, arrested cells induced late apoptosis and DNA degradation under dark condition. These results suggest that Pa isolated from G. elliptica is a potential glioblastoma-specific anticancer agent without side effects on normal cells. © 2014 by The Korean Society for Microbiology and Biotechnology.

Cite

CITATION STYLE

APA

Cho, M. L., Park, G. M., Kim, S. N., Amna, T., Lee, S., & Shin, W. S. (2014). Glioblastoma-specific anticancer activity of pheophorbide a from the edible red seaweed Grateloupia elliptica. Journal of Microbiology and Biotechnology, 24(3), 346–353. https://doi.org/10.4014/jmb.1308.08090

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free